T细胞表达AhR抑制急性GVHD胃肠道pTreg细胞的维持
研究在小鼠异基因骨髓移植模型中显示,接受AhR缺陷T细胞的小鼠生存改善、急性移植物抗宿主病(aGVHD)减轻;移植后4天AhR缺陷CD4+ T细胞因增殖低而在次级淋巴组织积聚减少,移植后14天结肠中外周诱导调节性供者T(pTreg)细胞数量显著增加;使用临床可及的AhR拮抗剂可增强人naïve CD4+ T细胞体外生成诱导性Treg(iTreg)细胞。
要点
- 接受AhR缺陷T细胞的小鼠在两种异基因骨髓移植模型中生存改善、aGVHD减轻。
- 移植后4天AhR缺陷CD4+ T细胞增殖低,次级淋巴组织积聚减少。
- 移植后14天接受AhR缺陷T细胞的小鼠结肠pTreg细胞数量显著增加。
核心结论
- AhR是供者T细胞上影响aGVHD发病机制的新靶点。
研究设计与样本
- 研究使用两种小鼠异基因骨髓移植模型,比较接受AhR缺陷T细胞与对照T细胞的小鼠。
主要发现
- 接受AhR缺陷T细胞的小鼠生存改善、aGVHD减轻。
- AhR缺陷CD4+ T细胞在移植后4天因增殖低而在次级淋巴组织积聚减少。
- 移植后14天接受AhR缺陷T细胞的小鼠结肠中pTreg细胞数量显著增加。
- 使用临床可及的AhR拮抗剂可大幅增强人naïve CD4+ T细胞体外生成iTreg细胞。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that affects the function and development of immune cells. Here, we show that recipient mice receiving AhR-/- T cells have improved survival and decreased acute graft-versus-host disease (aGVHD) in 2 different murine allogeneic bone marrow transplant (BMT) models. We also show that CD4+ T cells lacking AhR demonstrate reduced accumulation in secondary lymphoid tissue because of low levels of proliferation 4 days after BMT. Additionally, we found a significant increase in the quantity of peripherally induced regulatory donor T (pTreg) cells in the colon of recipients transplanted with AhR-/- T cells 14 days after transplant. Blockade of AhR using a clinically available AhR antagonist greatly enhanced the in vitro generation of inducible Treg (iTreg) cells from naïve CD4+ human T cells. We have identified AhR as a novel target on donor T cells that is critical to the pathogenesis of aGVHD.
引用
- Dant TA, Lin KL, Bruce DW, et al. T-cell expression of AhR inhibits the maintenance of pTreg cells in the gastrointestinal tract in acute GVHD. Blood. 2017. PMID: 28550042. doi:10.1182/blood-2016-08-734244
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。